{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T04:36:20Z","timestamp":1761885380437,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.acuroe.2022.12.003","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T12:00:49Z","timestamp":1672228849000},"page":"92-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of intravesical mitomycin compared with gemcitabine on the treatment non-muscle invasive bladder cancer: A meta-analysis"],"prefix":"10.1016","volume":"47","author":[{"given":"W.","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuroe.2022.12.003_bib0005","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder cancer incidence and mortality: a global overview and recent trends","volume":"71","author":"Antoni","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2022.12.003_bib0010","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/528353","article-title":"Pathobiology and chemoprevention of bladder cancer","volume":"2011","author":"Tanaka","year":"2011","journal-title":"J Oncol"},{"key":"10.1016\/j.acuroe.2022.12.003_bib0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jmoldx.2010.11.008","article-title":"Multiplexed methylation profiles of tumor suppressor genes in bladder cancer","volume":"13","author":"Cabello","year":"2011","journal-title":"J Molecular Diagnostics"},{"key":"10.1016\/j.acuroe.2022.12.003_bib0020","article-title":"Cancer incidence, mortality and prevalence worldwide","author":"Ferlay","year":"2004","journal-title":"GLOBOCAN2002"},{"key":"10.1016\/j.acuroe.2022.12.003_bib0025","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1007\/BF00686923","article-title":"The effects of intravesical chemoimmunotherapy with epirubicin and bacillus Calmette-Guerin for prophylaxis of recurrence of superficial bladder cancer: a preliminary report","volume":"35","author":"Uekado","year":"1994","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.acuroe.2022.12.003_bib0030","first-page":"1","article-title":"Approaches to reducing recurrence in superficial bladder cancer","volume":"1","author":"Ray","year":"2006","journal-title":"Eur Kidney Urol Dis"},{"key":"10.1016\/j.acuroe.2022.12.003_bib0035","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0022-5347(17)43644-5","article-title":"An overview of intravesical therapy for superficial bladder tumors","volume":"138","author":"Herr","year":"1987","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2022.12.003_bib0040","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.eursup.2007.01.028","article-title":"The treatment of non\u2013muscle-invasive bladder cancer with intravesical chemotherapy and immunotherapy","volume":"6","author":"Whelan","year":"2007","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.acuroe.2022.12.003_bib0045","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1200\/JCO.1997.15.11.3394","article-title":"Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer","volume":"15","author":"Stadler","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.acuroe.2022.12.003_bib0050","first-page":"3","article-title":"Gemcitabine: preclinical pharmacology and mechanisms of action","volume":"23","author":"Plunkett","year":"1996","journal-title":"Semin Oncol"},{"key":"10.1016\/j.acuroe.2022.12.003_bib0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00042307-200409000-00005","article-title":"Second-line intravesical therapy versus cystectomy for bacille Calmette-Guerin (BCG) failures","volume":"14","author":"Joudi","year":"2004","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.acuroe.2022.12.003_bib0060","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/COC.0000000000000388","article-title":"Obesity is independently associated with increased risk of hepatocellular cancer-related mortality","volume":"41","author":"Gupta","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.acuroe.2022.12.003_bib0065","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1200\/JCO.2008.20.8199","article-title":"Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance","volume":"28","author":"Addeo","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.acuroe.2022.12.003_bib0070","first-page":"1043","article-title":"Clinical effect of antineoplastic drug perfusion in preventing postoperative recurrence of superficial bladder cancer","volume":"17","author":"Xiaohong","year":"2015","journal-title":"J Chin Physician"},{"key":"10.1016\/j.acuroe.2022.12.003_bib0075","first-page":"118","article-title":"Comparison of the efficacy of different chemotherapy drugs in the prevention of postoperative recurrence in superficial bladder cancer by intravesical instillation","volume":"35","author":"Lin","year":"2016","journal-title":"China Foreign Med Treat"},{"key":"10.1016\/j.acuroe.2022.12.003_bib0080","first-page":"3238","article-title":"Comparison of intravesical perfusion of gemcitabine and mitomycin after non-muscle invasive bladder cancer","volume":"29","author":"Sun","year":"2016","journal-title":"J Med Theory Pract"},{"key":"10.1016\/j.acuroe.2022.12.003_bib0085","first-page":"109","article-title":"Curative effect analysis of different chemotherapeutics at intravesical instillation in the prevention of tumor recurrence after TUR-Bt","volume":"22","author":"Dong","year":"2017","journal-title":"Zhejiang J Traumat Surg"},{"key":"10.1016\/j.acuroe.2022.12.003_bib0090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3329\/bju.v22i1.50071","article-title":"Intravesical gemcitabine and mitomycin C chemotherapy in the treatment of non muscle invasive transitional cell carcinoma of urinary bladder\u2014a randommized clinical trial","volume":"22","author":"Alam","year":"2019","journal-title":"Bangladesh J Urol"},{"issue":"3","key":"10.1016\/j.acuroe.2022.12.003_bib0095","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2217\/imt.10.1","article-title":"Update on intravesical agents for non-muscle-invasive bladder cancer","volume":"2","author":"Shariat","year":"2010","journal-title":"Immunotherapy"},{"key":"10.1016\/j.acuroe.2022.12.003_bib0100","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1464-410X.2011.10880.x","article-title":"Intravesical gemcitabine therapy for non\u2010muscle invasive bladder cancer (NMIBC): a systematic review","volume":"109","author":"Shelley","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.acuroe.2022.12.003_bib0105","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1001\/jama.2018.4657","article-title":"Effect of intravesical instillation of gemcitabine vs saline immediately following resection of suspected low-grade non\u2013muscle-invasive bladder cancer on tumor recurrence: SWOG S0337 randomized clinical trial","volume":"319","author":"Messing","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.acuroe.2022.12.003_bib0110","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1200\/JCO.2005.05.2720","article-title":"Phase II trial of intravesical gemcitabine in bacille Calmette-Gu\u00e9rin\u2013refractory transitional cell carcinoma of the bladder","volume":"24","author":"Dalbagni","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.acuroe.2022.12.003_bib0115","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.urology.2005.04.062","article-title":"Intravesical gemcitabine therapy for superficial transitional cell carcinoma: results of a phase II prospective multicenter study","volume":"66","author":"Bartoletti","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.acuroe.2022.12.003_bib0120","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1586\/14737140.6.8.1273","article-title":"Intravesical mitomycin C for superficial transitional cell carcinoma","volume":"6","author":"Bolenz","year":"2006","journal-title":"Exp Rev Anticancer Ther"},{"key":"10.1016\/j.acuroe.2022.12.003_bib0125","article-title":"Intravesical gemcitabine for non-muscle invasive bladder cancer","volume":"1","author":"Jones","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.acuroe.2022.12.003_bib0130","unstructured":"Centers for Medicare & Medicaid Services. 2020 ASP Drug Pricing Files. [Accessed 12 December 2021]. Available from: https:\/\/www.cms.gov\/medicare\/medicare-part-b-drug-average-sales-price\/2020-asp-drug-pricing-files."}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578622001421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578622001421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:15:25Z","timestamp":1761880525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173578622001421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2173578622001421"],"URL":"https:\/\/doi.org\/10.1016\/j.acuroe.2022.12.003","relation":{},"ISSN":["2173-5786"],"issn-type":[{"type":"print","value":"2173-5786"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of intravesical mitomycin compared with gemcitabine on the treatment non-muscle invasive bladder cancer: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuroe.2022.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2022.03.007","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}